Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 387

Showing 26-50 of 387 citing articles:

Inflammasome formation in the lungs of patients with fatal COVID-19
Stefano Toldo, Rossana Bussani, Vincenzo Nuzzi, et al.
Inflammation Research (2020) Vol. 70, Iss. 1, pp. 7-10
Open Access | Times Cited: 133
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease
Ritu Pasrija, Mohammad Naime
International Immunopharmacology (2020) Vol. 90, pp. 107225-107225
Open Access | Times Cited: 102
A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19
Amit S. Lokhande, Padma V. Devarajan
European Journal of Pharmacology (2020) Vol. 891, pp. 173748-173748
Open Access | Times Cited: 102
Characterization of the SARS‐CoV‐2 E Protein: Sequence, Structure, Viroporin, and Inhibitors
Yipeng Cao, Rui Yang, Imshik Lee, et al.
Protein Science (2021) Vol. 30, Iss. 6, pp. 1114-1130
Open Access | Times Cited: 100
Innate Receptor Activation Patterns Involving TLR and NLR Synergisms in COVID-19, ALI/ARDS and Sepsis Cytokine Storms: A Review and Model Making Novel Predictions and Therapeutic Suggestions
Robert Root‐Bernstein
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2108-2108
Open Access | Times Cited: 95
SARS-CoV-2 Spike Glycoprotein S1 Induces Neuroinflammation in BV-2 Microglia
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Oyinkansola D. Adegbola, et al.
Molecular Neurobiology (2021) Vol. 59, Iss. 1, pp. 445-458
Open Access | Times Cited: 89
The role of host genetics in susceptibility to severe viral infections in humans and insights into host genetics of severe COVID-19: A systematic review
Abdelazeem Elhabyan, Saja Elyaacoub, Ehab Sanad, et al.
Virus Research (2020) Vol. 289, pp. 198163-198163
Open Access | Times Cited: 82
Why Does the Severity of COVID-19 Differ With Age?
Petra Zimmermann, Nigel Curtis
The Pediatric Infectious Disease Journal (2021) Vol. 41, Iss. 2, pp. e36-e45
Open Access | Times Cited: 76
Therapeutic potential of ginger against COVID-19: Is there enough evidence?
Abdollah Jafarzadeh, Sara Jafarzadeh, Maryam Nemati
Journal of Traditional Chinese Medical Sciences (2021) Vol. 8, Iss. 4, pp. 267-279
Open Access | Times Cited: 74
COVID-19 Impairs Immune Response to Candida albicans
Dominique Moser, Katharina Biere, Bing Han, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
COVID-19: Inflammatory Profile
Yuhang Wang, Stanley Perlman
Annual Review of Medicine (2021) Vol. 73, Iss. 1, pp. 65-80
Open Access | Times Cited: 71
The evolution of regulated cell death pathways in animals and their evasion by pathogens
Bart Tummers, Douglas R. Green
Physiological Reviews (2021) Vol. 102, Iss. 1, pp. 411-454
Open Access | Times Cited: 69
Endothelial cells and SARS-CoV-2: An intimate relationship
Lucas Cunha Barbosa, Thaynan Lopes Gonçalves, Luanna Prudencio de Araújo, et al.
Vascular Pharmacology (2021) Vol. 137, pp. 106829-106829
Open Access | Times Cited: 66
COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception—A Systematic Review
Tissa Wijeratne, Sheila G. Crewther, Carmela Sales, et al.
Frontiers in Neurology (2021) Vol. 11
Open Access | Times Cited: 65
Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID
Erin Clough, Joseph R. Inigo, Dhyan Chandra, et al.
Journal of Neuroimmune Pharmacology (2021) Vol. 16, Iss. 4, pp. 770-784
Open Access | Times Cited: 63
Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis
Huang Kai, Catherine Wang, Christen Vagts, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0261242-e0261242
Open Access | Times Cited: 61
Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone
Olumayokun A. Olajide, Victoria U. Iwuanyanwu, Izabela Lepiarz‐Raba, et al.
Inflammation (2021) Vol. 44, Iss. 5, pp. 1865-1877
Open Access | Times Cited: 60
Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Yaaser Q. Almulaiky, et al.
European Journal of Pharmacology (2021) Vol. 904, pp. 174196-174196
Open Access | Times Cited: 60
The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets
Rongrong Bai, Yue Lang, Jie Shao, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110181-175909142110181
Open Access | Times Cited: 60
Cannabinoids as Key Regulators of Inflammasome Signaling: A Current Perspective
Santosh Suryavanshi, Igor Kovalchuk, Olga Kovalchuk
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 57
Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID‐19‐associated thrombopathy
Antoine Caillon, Antonin Trimaille, Julie Favre, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 20, Iss. 1, pp. 17-31
Open Access | Times Cited: 56
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Luay Alkazmi, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 3, pp. 811-820
Open Access | Times Cited: 56
Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis
Durai Sellegounder, Parisa Zafari, Misagh Rajabinejad, et al.
International Immunopharmacology (2021) Vol. 98, pp. 107806-107806
Open Access | Times Cited: 55
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47

Scroll to top